Singapore markets close in 4 hours 41 minutes
  • Straits Times Index

    3,211.74
    +6.92 (+0.22%)
     
  • Nikkei

    32,661.37
    +258.96 (+0.80%)
     
  • Hang Seng

    17,833.29
    -224.16 (-1.24%)
     
  • FTSE 100

    7,683.91
    +5.29 (+0.07%)
     
  • Bitcoin USD

    26,176.11
    -399.58 (-1.50%)
     
  • CMC Crypto 200

    559.54
    -8.51 (-1.50%)
     
  • S&P 500

    4,320.06
    -9.94 (-0.23%)
     
  • Dow

    33,963.84
    -106.56 (-0.31%)
     
  • Nasdaq

    13,211.81
    -12.19 (-0.09%)
     
  • Gold

    1,942.70
    -2.90 (-0.15%)
     
  • Crude Oil

    90.21
    +0.18 (+0.20%)
     
  • 10-Yr Bond

    4.4380
    -0.0420 (-0.94%)
     
  • FTSE Bursa Malaysia

    1,442.03
    -8.20 (-0.57%)
     
  • Jakarta Composite Index

    7,019.06
    +2.22 (+0.03%)
     
  • PSE Index

    6,165.31
    +22.52 (+0.37%)
     

Is This Dow Jones Stock a Buy for Income Investors?

Is This Dow Jones Stock a Buy for Income Investors?

Replacing Pfizer (NYSE: PFE) as a component of the Dow Jones Industrial Average nearly three years ago, the pharmaceutical company Amgen (NASDAQ: AMGN) is among the best dividend payers in its industry. Let's dig into Amgen's fundamentals and valuation to get an answer to this question. With around 24,000 employees in total, Amgen is a major drugmaker with a $124 billion market capitalization.